Description

I help biotech, pharma, and diagnostics teams turn complex microbiology evidence into clear, go/no-go decisions. PhD microbiologist and former team lead (BIOASTER) with Medical Affairs experience, I specialise in biofilms, AMR, phages, antifungals, and the skin/mucosal microbiome. I bridge R&D ↔ business: aligning science, stakeholders, and timelines so projects de-risk faster and communicate better.

What you get

• Decision-ready briefs: ranked insights from literature & clinical trials + risks/next steps

• R&D strategy: model/screen selection (incl. biofilm), protocol critique, success criteria

• Diagnostics & claims: evidence mapping, substantiation, publication planning

• Competitive landscapes: pipelines, mechanisms, trials, KOLs, whitespace

• Executive storytelling: slide docs, congress coverage, messaging for MA/BD

How I work

Structured, fast, and pragmatic. I build lightweight AI/data workflows (PubMed/CT mining, trend tracking, basic analytics) to save time without black-box hype. Clear deliverables (slides/Word dashboards), regular check-ins, and sharp recommendations you can act on tomorrow. Remote EU/UK; on-site by request; NDA-friendly.

Keywords: microbiology, biofilms, antimicrobial resistance, phage therapy, antifungals, diagnostics, medical affairs, evidence generation, scientific communication, clinical trials, strategy, AI/data.

Industry field of expertise

Languages

Polish
Native or bilingual
English
Fluent
Dutch
Conversational

Workplace preferences

Can work on-site

Lyon (up to 50km)

MicroBioBridge Consulting
Founder & Life Science Consultant
BIOTECH
February 2025 - Today (1 year and 4 months)
Lyon, France
• Providing freelance scientific support in microbiology, medical affairs, and life sciences communication.
Microbiology Research Communication strategy Needs analysis Corporate strategy
BIOASTER
Team Leader Microbiology
December 2019 - August 2024 (4 years and 8 months)
Lyon, France
• Led cross-functional R&D teams in diagnostics, microbiota, and infectious diseases, managed collaborations with pharma, biotech, and research institutes.
• Development of BIOFILM-ID (biofilm profiling toolkit) and centralized Bacterial Strain Collection for industrial partnerships.
• Co-developed AI-powered platforms (HoloMoA, MetSaMoA, BIND-IT) for antibiotic mode-of-action prediction and molecular profiling including early-stage VHH-discovery workflow.
• Contributed to the strategic development of VHH discovery workflows by integrating display technologies, NGS, and structural modeling.
• Contributed scientific input to internal decision-making and stakeholder communications.
• Built strategic partnerships and drove co-development of microbiology solutions with external stakeholders.
• Mentored 3 scientists and students; aligned execution with key R&D milestones.
• Oversaw complex projects from concept to delivery under ISO 9001 and IVDR compliance.
• Keynote speaker at ESVB 2021 on biofilm innovation and translational research.
BIOASTER
Interim Manager of Microbiology Technological Unit
BIOTECH
January 2022 - June 2022 (5 months)
Lyon, France
• Directed 20 FTEs, aligning microbiology and preclinical operations with strategic goals.
• Led pharma collaborations to advance microbiology-based technologies toward commercialization.
• Secured ISO 9001 accreditation through quality system optimization and regulatory readiness.